Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001415889-24-016279

CHIEF OPERATING OFFICER sold 1,133 shares at $20.06 ($22,722)

  • CHIEF OPERATING OFFICER acquired 1,133 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Patel Anish · CHIEF OPERATING OFFICER

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-06-06 Exercise or conversion : show line 1 in the form 10b5-1 +1,133 $2.48 $2,810 1,133 D
2024-06-06 Sale : show line 2 in the form 10b5-1 −1,133 $20.06 $22,722 0 D
Open-market sales · 1,133 sh · avg $20.06 · $22,722

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-06-06 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (right to buy) −1,133 53,342 D
Loading xslF345X05/form4-06102024_100635.xml…